In vitro pharmacokinetics and pharmacodynamics of the diarylquinoline TBAJ-587 and its metabolites against Mycobacterium tuberculosis.

Aguilar-Ayala DA, Rabodoarivelo MS, Eveque-Mourroux MR, Leding AAM, Sonnenkalb L, Picó Marco A, Willand N, Serbina N, Simonsson USH, Lucía A, Ramón-García S

Open source

DOI: 10.3389/fmicb.2026.1828998
Published: 2026
Container: Frontiers in microbiology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmicb.2026.1828998,
  title = {In vitro pharmacokinetics and pharmacodynamics of the diarylquinoline TBAJ-587 and its metabolites against Mycobacterium tuberculosis.},
  author = {Aguilar-Ayala DA and Rabodoarivelo MS and Eveque-Mourroux MR and Leding AAM and Sonnenkalb L and Picó Marco A and Willand N and Serbina N and Simonsson USH and Lucía A and Ramón-García S},
  year = {2026},
  journal = {Frontiers in microbiology},
  doi = {10.3389/fmicb.2026.1828998},
  url = {https://doi.org/10.3389/fmicb.2026.1828998}
}

RIS

TY  - JOUR
TI  - In vitro pharmacokinetics and pharmacodynamics of the diarylquinoline TBAJ-587 and its metabolites against Mycobacterium tuberculosis.
AU  - Aguilar-Ayala DA
AU  - Rabodoarivelo MS
AU  - Eveque-Mourroux MR
AU  - Leding AAM
AU  - Sonnenkalb L
AU  - Picó Marco A
AU  - Willand N
AU  - Serbina N
AU  - Simonsson USH
AU  - Lucía A
AU  - Ramón-García S
PY  - 2026
JO  - Frontiers in microbiology
DO  - 10.3389/fmicb.2026.1828998
UR  - https://doi.org/10.3389/fmicb.2026.1828998
ER  -

APA

DA, A., MS, R., MR, E., AAM, L., L, S., A, P. M., N, W., N, S., USH, S., A, L., & S, R. (2026). In vitro pharmacokinetics and pharmacodynamics of the diarylquinoline TBAJ-587 and its metabolites against Mycobacterium tuberculosis.. Frontiers in microbiology. https://doi.org/10.3389/fmicb.2026.1828998

Source records

pubmed · retrieved 2026-09-27T09:58:55.770Z